Establishment of Relational Model of Congenital Heart Disease Markers and GO Functional Analysis of the Association Between Its Serum Markers and Susceptibility Genes

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2016 Apr 28

PMID 27118988

Citations 2

Authors

Min Liu

Luosha Zhao

Jiaying Yuan

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of present study was to construct the best screening model of congenital heart disease serum markers and to provide reference for further prevention and treatment of the disease.

Methods: Documents from 2006 to 2014 were collected and meta-analysis was used for screening susceptibility genes and serum markers closely related to the diagnosis of congenital heart disease. Data of serum markers were extracted from 80 congenital heart disease patients and 80 healthy controls, respectively, and then logistic regression analysis and support vector machine were utilized to establish prediction models of serum markers and Gene Ontology (GO) functional annotation.

Results: Results showed that NKX2.5, GATA4, and FOG2 were susceptibility genes of congenital heart disease. CRP, BNP, and cTnI were risk factors of congenital heart disease (p < 0.05); cTnI, hs-CRP, BNP, and Lp(a) were significantly close to congenital heart disease (p < 0.01). ROC curve indicated that the accuracy rate of Lp(a) and cTnI, Lp(a) and BNP, and BNP and cTnI joint prediction was 93.4%, 87.1%, and 97.2%, respectively. But the detection accuracy rate of the markers' relational model established by support vector machine was only 85%. GO analysis suggested that NKX2.5, GATA4, and FOG2 were functionally related to Lp(a) and BNP.

Conclusions: The combined markers model of BNP and cTnI had the highest accuracy rate, providing a theoretical basis for the diagnosis of congenital heart disease.

Citing Articles

Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy.

Gallicano G, Fu J, Mahapatra S, Sharma M, Dillon C, Deng C Pharmaceuticals (Basel). 2022; 15(7).

PMID: 35890169 PMC: 9317130. DOI: 10.3390/ph15070871.

The role of machine learning applications in diagnosing and assessing critical and non-critical CHD: a scoping review.

Helman S, Herrup E, Christopher A, Al-Zaiti S Cardiol Young. 2021; 31(11):1770-1780.

PMID: 34725005 PMC: 8805679. DOI: 10.1017/S1047951121004212.

References

Yang Y, Tang Y, Liu X, Lin X, Chen Y . [A novel GATA4 mutation leading to congenital ventricular septal defect]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010; 27(5):512-6. DOI: 10.3760/cma.j.issn.1003-9406.2010.05.008. View

Garg V, Kathiriya I, Barnes R, Schluterman M, King I, Butler C . GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003; 424(6947):443-7. DOI: 10.1038/nature01827. View

Tomita H, Takamuro M, Soda W, Hatakeyama K, Tsutsumi H . Increased serum high-sensitivity C-reactive protein is related to hypoxia and brain natriuretic peptide in congenital heart disease. Pediatr Int. 2009; 50(4):436-40. DOI: 10.1111/j.1442-200X.2008.02581.x. View

Tang Z, Xia L, Chang W, Li H, Shen F, Liu J . Two novel missense mutations of GATA4 gene in Chinese patients with sporadic congenital heart defects. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006; 23(2):134-7. View

Zhou F, Zhou C, Tian Y, Xiao A, Li P, Wang Y . Diagnostic value of analysis of H-FABP, NT-proBNP, and cTnI in heart function in children with congenital heart disease and pneumonia. Eur Rev Med Pharmacol Sci. 2014; 18(10):1513-6. View

Jiang Y, Guo K, Chen M, Bao J, Shen C, Li Y . Serum lipoprotein(a) positively correlates with coronary artery calcification in low-risk chinese han patients: a study from a single center. PLoS One. 2013; 8(8):e71673. PMC: 3741126. DOI: 10.1371/journal.pone.0071673. View

Li Z, Li G, Zhou Y, Chen Z, Yang J, Zhang Y . Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention. Lipids Health Dis. 2013; 12:127. PMC: 3766040. DOI: 10.1186/1476-511X-12-127. View

Pradat P, Francannet C, Harris J, Robert E . The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003; 24(3):195-221. DOI: 10.1007/s00246-002-9401-6. View

Lin C, Zeng X, Meng X, Jiang S, Ou-Yang H . [Clinical importance of preoperative measurement of plasma amino-terminal pro-B-type natriuretic peptide in infants with congenital heart disease]. Zhongguo Dang Dai Er Ke Za Zhi. 2014; 16(1):40-3. View

10.

Dadvand P, Rankin J, Rushton S, Pless-Mulloli T . Association between maternal exposure to ambient air pollution and congenital heart disease: A register-based spatiotemporal analysis. Am J Epidemiol. 2010; 173(2):171-82. PMC: 3011953. DOI: 10.1093/aje/kwq342. View

11.

Salazar M, Consoli F, Villegas V, Caicedo V, Maddaloni V, Daniele P . Search of somatic GATA4 and NKX2.5 gene mutations in sporadic septal heart defects. Eur J Med Genet. 2011; 54(3):306-9. DOI: 10.1016/j.ejmg.2011.01.004. View

12.

Pang S, Shan J, Qiao Y, Ma L, Qin X, Wanyan H . Genetic and functional analysis of the NKX2-5 gene promoter in patients with ventricular septal defects. Pediatr Cardiol. 2012; 33(8):1355-61. DOI: 10.1007/s00246-012-0346-0. View

13.

Kuciene R, Dulskiene V . Parental cigarette smoking and the risk of congenital heart septal defects. Medicina (Kaunas). 2011; 46(9):635-41. View

14.

Kamstrup P, Benn M, Tybjaerg-Hansen A, Nordestgaard B . Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation. 2007; 117(2):176-84. DOI: 10.1161/CIRCULATIONAHA.107.715698. View

15.

Huang W, Meng H, Qiao Y, Pang S, Chen D, Yan B . Two novel and functional DNA sequence variants within an upstream enhancer of the human NKX2-5 gene in ventricular septal defects. Gene. 2013; 524(2):152-5. DOI: 10.1016/j.gene.2013.04.043. View

16.

Charron F, Paradis P, Bronchain O, Nemer G, Nemer M . Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Mol Cell Biol. 1999; 19(6):4355-65. PMC: 104395. DOI: 10.1128/MCB.19.6.4355. View

17.

Momiyama Y, Ohmori R, Fayad Z, Tanaka N, Kato R, Taniguchi H . Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis. Atherosclerosis. 2012; 222(1):241-4. DOI: 10.1016/j.atherosclerosis.2012.02.008. View

18.

Zhang W, Shen L, Deng Z, Ding Y, Mo X, Xu Z . Novel missense variants of ZFPM2/FOG2 identified in conotruncal heart defect patients do not impair interaction with GATA4. PLoS One. 2014; 9(7):e102379. PMC: 4099368. DOI: 10.1371/journal.pone.0102379. View

19.

Lisowski L, Verheijen P, Copel J, Kleinman C, Wassink S, H A Visser G . Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis. Herz. 2010; 35(1):19-26. DOI: 10.1007/s00059-010-3244-3. View

20.

Ding J, Li K, Zhang X, Yao Y, Reng L, Tao S . [Preliminary exploration of transcription factor Nkx2.5 mutations and congenital heart diseases]. Zhonghua Yi Xue Za Zhi. 2009; 89(16):1114-6. View